BELLISSIMA LTD
Significant control: Ayesha Majida Qureshi (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
What does Bellissima Ltd sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
BELLISSIMA LTD is an active private limited company (company number 14298817) incorporated on 16 August 2022, registered in Mayfair. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest abridged accounts cover the period ending 31 August 2025, showing net assets of £2,527 and cash of £92, with 0 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets were unchanged on the prior period.
By net assets it sits in the upper half of 143 comparable companies in London (median £100, upper quartile £10k).
Ownership and control
- Miss Ayesha Majida Qureshi
- owns 75–100% of shares
- can appoint or remove directors
- can appoint or remove directors
- Miss Ayesha Majida Qureshi
- has significant influence or control
- Miss Kaainat Khan
- owns 50–75% of shares
- owns 75–100% of shares
- owns 50–75% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 16 August 20224 yrs ago
- Next accounts due
- 31 May 2027in 220 days
- Confirmation statement due
- 30 August 2027in 311 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £2,527 | £92 | — | £2,619 | — | — | 0 |
| 31 August 2024 | £2,526 | £93 | — | £2,619 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £2,527 at 31 August 2025
- Current assets below creditors within one yearCurrent ratio 0.04
- Incorporated two to five years agoIncorporated 16 August 2022
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 311 days
- Next accounts duein 220 days
- Accounts period endNet assets £2,527 · abridged accounts
- Accounts period endNet assets £2,526 · abridged accounts
- Incorporated
Similar companies in London
- ABG HEALTHCARE LTDLondon · inc. Aug 2022
- SUNSIDE PHARMA LIMITEDLondon · inc. Sept 2022
- RESOCANN LIMITEDLondon · inc. Sept 2022
- MODERNA BIOTECH MANUFACTURING UK LTDLondon · inc. Jun 2022
- DP GROUP LTDLondon · inc. Oct 2022
- TRES ALCHEMIX LTDLondon · inc. Oct 2022
All companies incorporated on 16 August 2022 · in Aug 2022.
Reminders for BELLISSIMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.